Penumbra (PEN) EBITDA (2014 - 2026)
Penumbra's (PEN) quarterly EBITDA came in at $38.2 million in Q1 2026, down 5.24% year-on-year from $40.4 million in Q1 2025, and down 35.45% on a QoQ basis from $59.2 million in Q4 2025.
Penumbra (PEN) EBITDA (2014 - 2026) Analysis & Trends
Penumbra (PEN) has 13 years of EBITDA data on file, last reported at $38.2 million in Q1 2026.
- On a quarterly basis, EBITDA fell 5.24% year-over-year to $38.2 million in Q1 2026; TTM through Mar 2026 was $187.1 million, a 398.65% increase from a year earlier, with the FY2025 full-year figure at $189.2 million, up 1939.54% from the prior year.
- EBITDA for Q1 2026 stood at $38.2 million, down from $59.2 million in the prior quarter.
- Over the last five years, EBITDA for PEN reached as high as $59.2 million in Q4 2025 and fell as low as -$81.0 million in Q2 2024.
- Historically, EBITDA has averaged $18.6 million across 5 years, with a median of $17.9 million in 2023.
- Across the five-year window, EBITDA jumped 12969.78% in 2023 and tumbled 552.57% in 2024, its largest moves.
- Year by year, EBITDA stood at $4.8 million in 2022, then surged by 624.79% to $35.0 million in 2023, then rose by 22.11% to $42.8 million in 2024, then jumped by 38.48% to $59.2 million in 2025, then sank by 35.45% to $38.2 million in 2026.
- Per Business Quant data, the three most recent EBITDA figures were $38.2 million in Q1 2026, $59.2 million in Q4 2025, and $48.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.35 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 936.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.87 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.10 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 477.60 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 255.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 282.15 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 515.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Penumbra | 12.48 Bn | 11.87 Bn | 253.41 Mn | 38.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 38.23 Mn |
| Dec 31, 2025 | 59.23 Mn |
| Sep 30, 2025 | 48.84 Mn |
| Jun 30, 2025 | 40.83 Mn |
| Mar 31, 2025 | 40.35 Mn |
| Dec 31, 2024 | 42.78 Mn |
| Sep 30, 2024 | 35.36 Mn |
| Jun 30, 2024 | -80.96 Mn |
| Mar 31, 2024 | 12.10 Mn |
| Dec 31, 2023 | 35.03 Mn |
| Sep 30, 2023 | 12.63 Mn |
| Jun 30, 2023 | 17.89 Mn |
| Mar 31, 2023 | 8.01 Mn |
| Dec 31, 2022 | 4.83 Mn |
| Sep 30, 2022 | 5.43 Mn |
| Jun 30, 2022 | -139,000.00 |
| Mar 31, 2022 | -4.05 Mn |
| Dec 31, 2021 | -40.06 Mn |
| Sep 30, 2021 | 8.78 Mn |
| Jun 30, 2021 | 10.31 Mn |